A threat to decentralised care for drug-resistant tuberculosis

Lancet Respir Med. 2020 Oct;8(10):950-952. doi: 10.1016/S2213-2600(20)30392-1.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antitubercular Agents / administration & dosage*
  • Drug Administration Schedule
  • Humans
  • Patient-Centered Care / organization & administration*
  • Tuberculosis, Multidrug-Resistant / drug therapy*
  • Tuberculosis, Multidrug-Resistant / epidemiology

Substances

  • Antitubercular Agents